Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
STARR trial of everolimus in kidney transplant recipients with NK-mediated rejection
2019-001849-41Phase 2Active
- Sponsor
- Hospices Civils de Lyon
- Start
- Jun 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, single-arm trial of everolimus in kidney allograft rejection, sponsored by Hospices Civils de Lyon. Primary endpoint: Relative change in estimated glomerular filtration rate. Started Jun 2019; status: active.
02
Drugs
everolimus
03
Conditions
kidney allograft rejection
Beyond the preview
Go deeper on 2019-001849-41.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2019-001849-41.